tesamorelin ipamorelin peptide + Blend — GHRH Research Tesamorelin + Ipamorelin (10/3 MG)

2006 Oct;84(4):830-4.

Tesamorelin + Ipamorelin Blend 10mg / 3mg 89,00 Tesamorelin / Ipamorelin 10 mg / 3 mg Grail Formula Quality

Ipamorelin CERTIFICATES OF ANALYSIS 5 COAs BN-26IP02-001 Current Variant: Size: 2mg Ipamorelin 1.98 mg / 1.93 mg Purity 99.764% / 99.743% BN-25IP10-002 Current Variant: Size: 10mg Ipamorelin 10.38 mg Purity 99.95% BN-25IP05-003 Current Variant: Size: 5mg Ipamorelin 5.1 mg Purity 99.927% BN-25IP10-001 Previous Variant: Size: 10mg BN-25IP05-001 Previous Variant: Size: 5mg Formulation Ipamorelin is a single-peptide research formulation supplied for use in controlled laboratory and analytical environments

Weeks 1-4: Foundation Phase Improved sleep onset and continuity Mild increase in daily energy levels Reduced morning stiffness or exercise-related soreness Subtle improvements in mood and sense of well-being Some patients report more vivid dreams During this phase, sermorelin is beginning to restore pulsatile GH release patterns

What is the most important COA requirement

Treats Pigmentation : Glutathione reduces pigmentation by slowing down melanin synthesis in the skin